CURE Pharma (CURR) Interviewed at CFN

CURE Pharmaceutical Holdings Corp. (OTC: CURR) was founded by six individuals with experience in the pharmaceutical industry working with companies like Amgen Inc. (NASDAQ: AMGN) and Merck & Co. Inc. (NYSE: MRK).

With a focus on pediatrics and geriatrics, the company developed an oral thin film delivery system that it is using to address conditions ranging from cancer and its side-effects to neurological diseases.

For more interesting curated articles like this, sign up for our free newsletter at the MarijuanaStockReview.com or click here to subscribe.